Determination of phloroglucinol in human plasma by high-performance liquid chromatography-mass spectrometry

J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 25;792(2):307-12. doi: 10.1016/s1570-0232(03)00316-7.

Abstract

A sensitive and selective liquid chromatographic method coupled with mass spectrometry (LC-MS) was developed for the quantification of phloroglucinol in human plasma. Resorcinol was used as internal standard, with plasma samples extracted using ethyl acetate. A centrifuged upper layer was then evaporated and reconstituted with mobile phase. The reconstituted samples were injected into a C(18) XTerra MS column (2.1 x 100 mm) with 3.5-microm particle size. The analytical column lasted for at least 500 injections. The mobile phase was 15% acetonitrile (pH 3.0), with flow-rate at 200 microl/min. The mass spectrometer was operated in negative ion mode with selective ion monitoring (SIM). Phloroglucinol was detected without severe interferences from plasma matrix when used negative ion mode. Phloroglucinol produced a parent molecule ([M-H](-)) at m/z 125 in negative ion mode. Detection of phloroglucinol in human plasma was accurate and precise, with quantification limit at 5 ng/ml. This method has been successfully applied to a study of phloroglucinol in human specimens.

Publication types

  • Validation Study

MeSH terms

  • Adult
  • Calibration
  • Chromatography, High Pressure Liquid / methods*
  • Humans
  • Male
  • Phloroglucinol / blood*
  • Phloroglucinol / pharmacokinetics
  • Reference Standards
  • Reproducibility of Results
  • Spectrometry, Mass, Electrospray Ionization / methods*

Substances

  • Phloroglucinol